معرفی
Dr. Esther Lim is a Senior Lecturer at the Macquarie Medical School, Macquarie University. She leads research in the Precision Cancer Therapy (PCT) group, focusing on transcriptomic/proteomic profiles of melanoma patients undergoing immunotherapy and kinase inhibitor treatments. Her work aims to translate immune response mechanisms into clinical applications to improve cancer therapy efficacy.
Education: PhD in Pathology (University of New South Wales, 2006-2010), Bachelor of Science in Biotechnology (UNSW). Previously a postdoctoral researcher at the University of Oxford (2011-2015), studying immune cell roles in colorectal cancer metastasis. Early career included research assistant roles producing monoclonal antibodies for clinical trials.
Research Interests
- Cancer cell biology and tumor immunology
- Mechanisms of immune responses in cancer progression
- Biomarkers for melanoma prognosis and therapy response
Key Projects
- Differential effects of MAPK inhibition on immune activity (ongoing)
- Single-cell fluorescent imaging platform development (2018)
Grants & Collaborations - Active in interdisciplinary collaborations, particularly in immunotherapy and genomics.
